Sialic acid O-acetylation: From biosynthesis to roles in health and disease.
O-acetylation
glycan modifications
glycobiology
influenza C/D virus
sialic acid O-acetyl esterases (SIAEs)
sialic acid O-acetyl transferases (SOATs)
sialic acids
Journal
The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
05
04
2021
revised:
16
06
2021
accepted:
18
06
2021
pubmed:
23
6
2021
medline:
15
12
2021
entrez:
22
6
2021
Statut:
ppublish
Résumé
Sialic acids are nine-carbon sugars that frequently cap glycans at the cell surface in cells of vertebrates as well as cells of certain types of invertebrates and bacteria. The nine-carbon backbone of sialic acids can undergo extensive enzymatic modification in nature and O-acetylation at the C-4/7/8/9 position in particular is widely observed. In recent years, the detection and analysis of O-acetylated sialic acids have advanced, and sialic acid-specific O-acetyltransferases (SOATs) and O-acetylesterases (SIAEs) that add and remove O-acetyl groups, respectively, have been identified and characterized in mammalian cells, invertebrates, bacteria, and viruses. These advances now allow us to draw a more complete picture of the biosynthetic pathway of the diverse O-acetylated sialic acids to drive the generation of genetically and biochemically engineered model cell lines and organisms with altered expression of O-acetylated sialic acids for dissection of their roles in glycoprotein stability, development, and immune recognition, as well as discovery of novel functions. Furthermore, a growing number of studies associate sialic acid O-acetylation with cancer, autoimmunity, and infection, providing rationale for the development of selective probes and inhibitors of SOATs and SIAEs. Here, we discuss the current insights into the biosynthesis and biological functions of O-acetylated sialic acids and review the evidence linking this modification to disease. Furthermore, we discuss emerging strategies for the design, synthesis, and potential application of unnatural O-acetylated sialic acids and inhibitors of SOATs and SIAEs that may enable therapeutic targeting of this versatile sialic acid modification.
Identifiants
pubmed: 34157283
pii: S0021-9258(21)00706-7
doi: 10.1016/j.jbc.2021.100906
pmc: PMC8319020
pii:
doi:
Substances chimiques
Glycoproteins
0
Polysaccharides
0
Acetyltransferases
EC 2.3.1.-
sialic acid O-acetyltransferase
EC 2.3.1.-
Carboxylic Ester Hydrolases
EC 3.1.1.-
N-Acetylneuraminic Acid
GZP2782OP0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
100906Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.